Display Options:
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Heavy metals chelating agent
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Voltage-gated T-type calcium channel blocker
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Epilepsy
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Venous Insufficiency; Varicose Veins
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dopamine D1 receptor antagonist
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Hemorrhage
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Migraine with Aura; Migraine without Aura; Migraine Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Mu opioid receptor agonist
ROUTE OF ADMINISTRATION: FOR RX COMPOUNDING; INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: HIV Infections; Intervertebral Disc Degeneration; Acute Pain; Opioid-Related Disorders; Pain; Substance-Related Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial penicillin-binding protein inhibitor
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Carcinoma, Squamous Cell; Neoplasms; Stomach Neoplasms; Bacteremia; Infections; Pharyngitis; Pneumococcal Infections; Pneumonia; Tonsillitis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Thyroid peroxidase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Graves Ophthalmopathy; Thyrotoxicosis; Hyperthyroidism; Thyroid Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Pharyngitis; Rheumatic Heart Disease; Syphilis; Bacterial Infections; Eye Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Estrogen receptor alpha agonist
ROUTE OF ADMINISTRATION: VAGINAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hepatitis C; Premature Birth; Neonatal Abstinence Syndrome; Restless Legs Syndrome; Adenocarcinoma; Chronic Pain; Cocaine-Related Disorders; HIV Infections; Heroin Dependence; Neoplasms; Neuralgia; Neuralgia, Postherpetic; Opioid-Related Disorders; Renal Insufficiency, Chronic; Scoliosis; Pain; Substance-Related Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sodium channel alpha subunit blocker
ROUTE OF ADMINISTRATION: BUCCAL; ORAL; RECTAL; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: DENTISTRY; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
THERAPEUTIC INDICATION: Brain Neoplasms; Carcinoma, Squamous Cell; Glioblastoma; Glycogen Storage Disease Type II; Hypertension, Pulmonary; Keratosis, Actinic; Lung Neoplasms; Neoplasms, Cystic, Mucinous, and Serous; Neuroma; Premature Birth; Thromboembolism; Anus Diseases; Anxiety; Carcinoma; Cocaine-Related Disorders; Cognitive Dysfunction; Cystitis, Interstitial; Diabetic Neuropathies; Dysmenorrhea; Heart Diseases; Humeral Fractures; Infertility; Irritable Bowel Syndrome; Leiomyoma; Macular Degeneration; Myofascial Pain Syndromes; Neoplasms; Osteoarthritis, Knee; Renal Colic; Rib Fractures; Scleroderma, Localized; Severe Acute Respiratory Syndrome; Shoulder Impingement Syndrome; Shoulder Pain; Skin Diseases; Temporomandibular Joint Disorders; Trigeminal Neuralgia; Urinary Incontinence; Urinary Tract Infections; Breast Neoplasms; Carpal Tunnel Syndrome; Chronic Pain; Colorectal Neoplasms; Common Cold; Cough; Dysuria; Fibromyalgia; Headache; Heart Arrest; Hemorrhage; Ileus; Low Back Pain; Migraine Disorders; Muscular Diseases; Nutrition Disorders; Obesity; Obesity, Morbid; Osteoporosis, Postmenopausal; Paget Disease, Extramammary; Parathyroid Diseases; Periarthritis; Peripheral Nervous System Diseases; Pharyngitis; Pre-Eclampsia; Pregnancy; Pulpitis; Scoliosis; Shock, Septic; Sinusitis; Stomatitis; Stroke; Tennis Elbow; Urinary Bladder, Overactive; Uterine Cervical Dysplasia; Wounds and Injuries; Arrhythmias, Cardiac; Arthritis; Back Pain; Burns; Bursitis; Hemorrhoids; Inflammation; Insect Bites and Stings; Muscle Cramp; Myalgia; Neuralgia; Neuralgia, Postherpetic; Osteoarthritis; Pain; Premature Ejaculation; Pruritus; Rectal Diseases; Sprains and Strains; Sunburn; Tendinopathy; Urethritis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Adenosine receptor antagonist
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Alcoholism; Amblyopia; Amyotrophic Lateral Sclerosis; Anemia; Arthritis, Rheumatoid; Chronic Pain; Colitis, Ulcerative; Communicable Diseases; Crohn Disease; Dermatitis, Atopic; Diabetes Mellitus, Type 2; Endotoxemia; HIV Infections; Hepatitis C, Chronic; Hypotension, Orthostatic; Melanoma; Mitochondrial Diseases; Narcolepsy; Neoplasms; Non-alcoholic Fatty Liver Disease; Prostatic Neoplasms, Castration-Resistant; Psoriasis; Spinal Cord Injuries; Substance-Related Disorders; Breast Neoplasms; Cocaine-Related Disorders; Dyspnea; Memory Disorders; Tension-Type Headache; Alzheimer Disease; Atrial Fibrillation; Back Pain; Common Cold; Coronary Disease; Dysmenorrhea; Headache; Hypoxia; Intermittent Claudication; Low Back Pain; Migraine with Aura; Migraine without Aura; Multiple Sclerosis, Relapsing-Remitting; Neck Pain; Obesity; Parkinson Disease; Toothache; Apnea; Attention Deficit Disorder with Hyperactivity; Migraine Disorders; Pain
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sodium channel alpha subunit blocker
ROUTE OF ADMINISTRATION: INJECTION; INTRADERMAL; OPHTHALMIC; ORAL; SPINAL; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: EYE; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
THERAPEUTIC INDICATION: Hypertension; Chronic Pain; Headache; Hemorrhoids; Liver Neoplasms; Mucositis; Neoplasms; Pruritus; Rotator Cuff Injuries; Thalassemia; Wounds and Injuries; Diabetes Mellitus; Migraine Disorders; Pregnancy; Anesthesia; Back Pain; Pain; Prostatic Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Infections; Rhinitis, Allergic, Seasonal; Postoperative Nausea and Vomiting
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Bacterial Infections; Sepsis; Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Muscarinic acetylcholine receptor M2 agonist
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Urinary Retention
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hypersensitivity; Pruritus
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hypersensitivity
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Bacterial Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Adrenergic receptor alpha agonist
ROUTE OF ADMINISTRATION: INHALATION; SUBLINGUAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Headache; Migraine Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hypotension, Orthostatic; Migraine Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Diabetes Mellitus, Type 2; Eosinophilic Esophagitis; Pancreatic Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial dihydropteroate synthase inhibitor
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Bacterial Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Dystonic Disorders; Parkinson Disease
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hodgkin Disease; Lichen Planus; Mycosis Fungoides; Lymphoma; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Voltage-gated T-type calcium channel blocker
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Epilepsy
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Scabies
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Ferriprotoporphyrin IX inhibitor
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Lupus Erythematosus, Systemic; Arthritis, Rheumatoid
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Carcinoma, Intraductal, Noninfiltrating; Gliosarcoma; Neoplasms; Pancreatic Neoplasms; Severe Dengue; Small Cell Lung Carcinoma; Acquired Immunodeficiency Syndrome; Anemia, Sickle Cell; Brain Diseases; Breast Neoplasms; HIV Infections; Influenza, Human; Lupus Erythematosus, Systemic; Multiple Myeloma; Arthritis, Rheumatoid; Glioblastoma; Malaria, Falciparum; Malaria, Vivax; Pregnancy; Severe Acute Respiratory Syndrome; Malaria
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Ferriprotoporphyrin IX inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Atrial Fibrillation; HIV Infections; Lupus Erythematosus, Systemic; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Arthritis, Rheumatoid; Malaria
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Muscarinic acetylcholine receptor M1 antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INJECTION; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: DERMATOLOGY; OTHER
THERAPEUTIC INDICATION: Central Nervous System Neoplasms; Mycosis Fungoides; Lymphoma; Lymphoma, T-Cell, Cutaneous
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Bacterial enoyl-[acyl-carrier-protein] reductase inhibitor
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown